A systemic review and meta-analysis of Aflibercept plus FOLFIRI regimen as a second-line treatment for metastatic colorectal cancer: A PRISMA compliant pooled analysis of randomized controlled trials and single arm studies to assess efficacy and safety
Anshu Thakur, Mehul R. Chorawala, Roshni S. Patel
Topics & Concepts
FOLFIRIMedicineAfliberceptInternal medicineBevacizumabIrinotecanOncologyRegimenRandomized controlled trialAdverse effectColorectal cancerChemotherapy regimenSurgeryChemotherapyCancerColorectal Cancer Treatments and StudiesAngiogenesis and VEGF in CancerCancer Research and Treatments